[
Beam Therapeutics Presents Additional Data for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at 2025 Alpha-1 Foundation 7th Global Research Conference and 10th Patient Congress
[og_img]
https://www.investing.com/news/press-releases/beam-therapeutics-presents-additional-data-for-beam302-in-alpha1-antitrypsin-deficiency-aatd-at-2025-alpha1-foundation-7th-global-research-conference-and-10th-patient-congress-93CH-3969453
Investing.com
Beam Therapeutics Presents Additional Data for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at 2025 Alpha-1 Foundation 7th Global Research Conference and 10th Patient Congress
Related articles